Casoy Julio 4
4 · ArTara Therapeutics, Inc. · Filed Jan 13, 2020
Insider Transaction Report
Form 4
Casoy Julio
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-01-09+38,151→ 38,151 totalExercise: $9.18Exp: 2029-04-28→ Common Stock (38,151 underlying) - Award
Common Stock
2020-01-10+45,500→ 45,500 total
Footnotes (4)
- [F1]The shares being reported are being issued pursuant to restricted stock unit awards ("RSUs"), each one of which represents a contingent right to receive one share of Issuer's common stock. 25% of the shares vest on each one-year anniversary of January 10, 2020.
- [F2]On September 23, 2019, the Issuer entered into an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") as amended on November 19, 2019, with the Issuer, REM 1 Acquisition, Inc. ("Merger Sub") and ArTara Subsidiary, Inc. ("ArTara Sub"). On January 9, 2020 (the "Effective Time"), Merger Sub was merged with and into ArTara Sub, with ArTara Sub surviving as a wholly owned subsidiary of the Issuer.
- [F3]1/48th of the shares subject to the option shall vest monthly following February 1, 2019, for so long as the Reporting Person provides continuous service to the Issuer.
- [F4]Received in the Merger in exchange for an employee stock option to acquire 200,000 shares of ArTara Sub common stock for $1.75 per share.